P. Davol

发表

Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.

P. Davol, A. Bizuneh, A. Frackelton, 1999, Anticancer research.

Redirected T‐cell cytotoxicity to epithelial cell adhesion molecule‐overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model

L. Lum, P. Davol, N. Kouttab, 2004, Cancer.

Acknowledgement

D. Busch, H. Einsele, M. Dhodapkar, 1987, Hearing Research.

Antibody Targeting of Stem Cells to Infarcted Myocardium

Randall J. Lee, J. Padbury, J. Larrick, 2007, Stem cells.

Phase I trial of anti-PSMA designer T cells in advanced prostate cancer.

E. Beaudoin, R. Junghans, P. Davol, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model

P. Davol, A. Frackelton, S. Garza, 1999, Cancer.

Retargeting T cells and immune effector cells with bispecific antibodies.

L. Lum, P. Davol, 2005, Cancer chemotherapy and biological response modifiers.

Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance

P. Davol, A. Frackelton, 1999, The Prostate.

Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line.

P. Davol, A. Frackelton, J. Beitz, 1995, The Journal of investigative dermatology.

Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart.

J. Padbury, Y. Tseng, N. Yano, 2010, Cardiovascular research.

Human T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation

L. Lum, P. Davol, W. Young, 2006, Clinical Cancer Research.

Human TCells Armedwith Her 2 / neu Bispecific Antibodies Divide , Are Cytotoxic , and Secrete Cytokineswith Repeated Stimulation

L. Lum, P. Davol, W. Young, 2006 .

Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model

J. Cook, D. Lappi, W. Ying, 1995, Cancer.

Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.

J. Clark, D. Lappi, A. Baird, 1992, Cancer research.

T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.

L. Lum, P. Davol, Ryan C. Grabert, 2005, Experimental hematology.

The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model.

P. Davol, A. Frackelton, 1996, The Journal of urology.

Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.

P. Davol, J. Darnowski, F. A. Goulette, 1997, Biochemical pharmacology.

Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas.

L. Lum, P. Davol, Ryan C. Grabert, 2005, Anticancer research.

Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.

R. Bagdasaryan, P. Davol, A. Frackelton, 2003, Cancer research.

Modulation of p53 expression by human recombinant interferon-alpha2a correlates with abrogation of cisplatin resistance in a human melanoma cell line.

P. Davol, A. Frackelton, J. Darnowski, 1996, Cancer research.

The new face of bispecific antibodies: targeting cancer and much more.

Randall J Lee, L. Lum, P. Davol, 2006, Experimental hematology.

Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice.

L. Lum, P. Davol, N. Kouttab, 2004, Clinical prostate cancer.

How important is HER2/neu amplification and expression when selecting patients for HER2/neu-targeted therapies?

L. Lum, P. Davol, 2004, Clinical breast cancer.

p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy

D. Sgroi, L. Hafer, R. Bagdasaryan, 2006, Breast Cancer Research.

Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction.

J. Padbury, N. Yano, L. Lum, 2008, Journal of applied physiology.

Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers In vitro and in an Animal Model

L. Lum, P. Davol, M. Sundaram, 2006, Clinical Cancer Research.

Virtual reality of stem cell transplantation to repair injured myocardium

J. Padbury, L. Lum, P. Davol, 2005, Journal of cellular biochemistry.

Anti-CD 3 Anti-Epidermal Growth Factor Receptor ( EGFR ) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers In vitro and in an AnimalModel

Paul Liu, L. Lum, P. Davol, 2005 .